CS
LOXO

Credit Suisse’s Loxo Oncology, Inc LOXO Stock Holding History

Credit Suisse’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-149,228
Closed -$20.9M – 4239
2018
Q4 		$20.9M Buy
149,228
+6,090
+4% +$924K 0.02% 773
2018
Q3 		$24.5M Buy
143,138
+14,227
+11% +$2.39M 0.02% 768
2018
Q2 		$22.4M Sell
128,911
-57,080
-31% -$8.58M 0.02% 780
2018
Q1 		$21.5M Buy
185,991
+67,930
+58% +$7.23M 0.02% 818
2017
Q4 		$9.94M Buy
118,061
+47,224
+67% +$3.94M 0.01% 1297
2017
Q3 		$6.53M Buy
70,837
+13,613
+24% +$1.06M 0.01% 1555
2017
Q2 		$4.59M Sell
57,224
-20,438
-26% -$1.13M ﹤0.01% 1680
2017
Q1 		$3.27M Buy
77,662
+35,506
+84% +$1.46M ﹤0.01% 1969
2016
Q4 		$1.35M Buy
+42,156
New +$1.08M ﹤0.01% 2777
2016
Q3 		– Sell
-10,509
Closed -$243K – 4348
2016
Q2 		$243K Buy
+10,509
New +$262K ﹤0.01% 3784

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Credit Suisse's LOXO Position: Q1 2019 in Review

Credit Suisse sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 149,228 shares — an estimated $20.9M sold.

Credit Suisse first reported a position in LOXO in Q2 2016 and held it in 10 quarters. The position peaked at $24.5M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Credit Suisse reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Credit Suisse sold 149,228 Loxo Oncology, Inc shares in Q1 2019, an estimated $20.9M.
  • Credit Suisse first reported a position in Loxo Oncology, Inc in Q2 2016 and held it in 10 quarters.
  • Credit Suisse's Loxo Oncology, Inc position peaked at $24.5M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Credit Suisse's 13F filing for Q1 2019, filed 14 May 2019.